Clinical trial
Speech Guided Breathing: a Modality to Influence Cardiovascular Regulation and Health Perception in Hypertensive Patients?
NCT02681484 is registered in ClinicalTrials.gov with Klinik Arlesheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Speech Guided Breathing: a Modality to Influence Cardiovascular Regulation and Health Perception in Hypertensive Patients?
- Lead sponsor
- Klinik Arlesheim
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2002
- Completion date
- April 30, 2008
- Enrollment
- 31 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.